FDA Grants Breakthrough Designation to 4D Path for Novel Cancer Diagnostic Solution

by NASDAQ Market News November 18, 2020

NASDAQ Market News
Click here to email author

Tiziana Life Sciences PLC (“Tiziana” or the “Company”) – PDMR Dealing

A review article defines LIDDS as a key player in TLR9 agonist research field and being the only provider having a sustained release product in development

Ads